E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts

Oncogene

Volumn 25, Issue 23, 2006, Pages 3258-3266

  Frame, F M ^a   Rogoff, H A ^a   Pickering, M T ^a   Cress, W D ^b   Kowalik, T F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Cell cycle checkpoint; DNA damage; E2F1

Indexed keywords

HISTONE H2AX; NIBRIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DEREGULATION; DNA BINDING; DNA STRAND BREAKAGE; FIBROBLAST; HUMAN; HUMAN CELL; IRRADIATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REGULATORY MECHANISM; SERUM; TUMOR CELL;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; E2F1 TRANSCRIPTION FACTOR; FIBROBLASTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33744934811     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209352     Document Type: Article

References (49)

1. Anderson L, Henderson C, Adachi Y. (2001). Mol Cell Biol 21: 1719-1729.
2. Bartek J, Lukas J. (2001a). Curr Opin Cell Biol 13: 738-747.
3. Bartek J, Lukas J. (2001b). FEBS Lett 490: 117-122.
4. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). Nature 434: 864-870.
5. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates III JR et al. (1998). Cell 93: 477-486.
6. Castillo JP, Yurochko AD, Kowalik TF. (2000). J Virol 74: 8028-8037.
7. Cobrinik D. (2005). Oncogene 24: 2796-2809.
8. Cress WD, Nevins JR. (1994). J Virol 68: 4213-4219.
9. D'Amours D, Jackson SP. (2002). Nat Rev Mol Cell Biol 3: 317-327.
10. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. (1997). Proc Natl Acad Sci USA 94: 7245-7250.
11. Dimri GP, Itahana K, Acosta M, Campisi J. (2000). Mol Cell Biol 20: 273-285.
12. DiTullio Jr RA, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J et al. (2002). Nat Cell Biol 4: 998-1002.
13. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 75: 817-825.
14. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J et al. (1994). Cancer Res 54: 1169-1174.
15. Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC et al. (2002). Nat Cell Biol 4: 993-997.
16. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Nature 434: 907-913.
17. Hanahan D, Weinberg RA. (2000). Cell 100: 57-70.
18. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. (1998). Proc Natl Acad Sci USA 95: 2509-2514.
19. Johnson DG, Schwarz JK, Cress WD, Nevins JR. (1993). Nature 365: 349-352.
20. Jongmans W, Vuillaume M, Chrzanowska K, Smeets D, Sperling K, Hall J. (1997). Mol Cell Biol 17: 5016-5022.
21. Kastan MB, Lim DS. (2000). Nat Rev Mol Cell Biol 1: 179-186.
22. Kobayashi J, Tauchi H, Sakamoto S, Nakamura A, Morishima K, Matsuura S et al. (2002). Curr Biol 12: 1846-1851.
23. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. (1995). J Virol 69: 2491-2500.
24. Lindstrom MS, Wiman KG. (2003). Oncogene 22: 4993-5005.
25. Lomazzi M, Moroni MC, Jensen MR, Frittoli E, Helin K. (2002). Nat Genet 31: 190-194.
26. Lombard DB, Guarente L. (2000). Cancer Res 60: 2331-2334.
27. Maser RS, Mirzoeva OK, Wells J, Olivares H, Williams BR, Zinkel RA et al. (2001). Mol Cell Biol 21: 6006-6016.
28. Maser RS, Monsen KJ, Nelms BE, Petrini JH. (1997). Mol Cell Biol 17: 6087-6096.
29. Meek DW. (2004). DNA Repair (Amst) 3: 1049-1056.
30. Mirzoeva OK, Petrini JH. (2001). Mol Cell Biol 21: 281-288.
31. Munger K, Howley PM. (2002). Virus Res 89: 213-228.
32. Nelms BE, Maser RS, MacKay JF, Lagally MG, Petrini JH. (1998). Science 280: 590-592.
33. Oren M. (2003). Cell Death Differ 10: 431-442.
34. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. (2000). Curr Biol 10: 886-895.
35. Pickering MT, Kowalik TF. (2005). Oncogene, advance online publication, 26/9/05 (doi: 10.1038/sj.onc.1209103).
36. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. (2004). Mol Cancer Res 2: 203-214.
37. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. (1998). J Biol Chem 273: 5858-5868.
38. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF. (2002). Mol Cell Biol 22: 5308-5318.
39. Rogoff HA, Pickering MT, Frame FM, Debatis ME, Sanchez Y, Jones S et al. (2004). Mol Cell Biol 24: 2968-2977.
40. Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. (2002). Mol Cell Biol 22: 1360-1368.
41. Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S et al. (1995). Proc Natl Acad Sci USA 92: 483-487.
42. Shiloh Y. (1997). Annu Rev Genet 31: 635-662.
43. Shiloh Y. (2003). Nat Rev Cancer 3: 155-168.
44. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG et al. (1999). Cell 99: 577-587.
45. Taalman RD, Jaspers NG, Scheres JM, de Wit J, Hustinx TW. (1983). Mutat Res 112: 23-32.
46. Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T. (2002). Mol Cell Biol 22: 370-377.
47. Tsai KY, MacPherson D, Rubinson DA, Crowley D, Jacks T. (2002). Curr Biol 12: 159-163.
48. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. (2002). Science 298: 1435-1438.
49. Wu G, Lee WH, Chen PL. (2000). J Biol Chem 275: 30618-30622.